[New devices for the invasive treatment of acute myocardial infarction]

Gennaro Sardella1, Rachele Adorisio, Leonardo De Luca

  • 1Dipartimento di Scienze Cardiovascolari e Respiratorie, Università degli Studi La Sapienza, Roma. rino.sardella@uniroma1.it

Insights

Primary angioplasty is the best treatment for acute myocardial infarction, but distal embolization can reduce its effectiveness. New thrombectomy and distal protection devices aim to improve outcomes by preventing this complication.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Context:

  • Acute myocardial infarction (AMI) treatment relies on timely reperfusion.
  • Primary angioplasty is the gold standard for reperfusion in AMI.
  • Distal embolization is a significant complication limiting angioplasty efficacy in AMI.

Purpose:

  • To review available thrombectomy and distal protection devices for managing distal embolization during primary angioplasty.
  • To highlight devices used in the cardiac catheterization laboratory (cath lab) to mitigate embolization risks.

Summary:

  • Primary angioplasty effectively restores blood flow in acute myocardial infarction (AMI).
  • Distal embolization, where clot fragments travel distally, impairs angioplasty outcomes.
  • Various thrombectomy and distal protection devices are now available to prevent embolization during cardiac procedures.

Impact:

  • Improved patient prognosis by reducing complications associated with distal embolization.
  • Enhanced efficacy of primary angioplasty in acute myocardial infarction.
  • Advancements in interventional cardiology through novel device development for embolic protection.